Vigilare Wealth Management Amarin Corp Plcuk Transaction History

Vigilare Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 16, 2021	SELL	$4.26 - $6.5 $80,024 - $122,102	-18,785 Closed	0 $0
Q4 2020 Jan 14, 2021	SELL	$4.04 - $5.31 $16,160 - $21,240	-4,000 Reduced 17.56%	18,785 $92,000
Q3 2020 Oct 15, 2020	SELL	$3.64 - $7.76 $9,100 - $19,400	-2,500 Reduced 9.89%	22,785 $96,000
Q2 2020 Jul 20, 2020	SELL	$4.78 - $8.26 $57,063 - $98,607	-11,938 Reduced 32.07%	25,285 $175,000
Q1 2020 May 04, 2020	BUY	$4.0 - $21.53 $70,176 - $377,722	17,544 Added 89.15%	37,223 $149,000
Q4 2019 Feb 13, 2020	BUY	$13.94 - $24.12 $274,325 - $474,657	19,679 New	19,679 $362,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $194M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Vigilare Wealth Management with notifications on news.